Bradley C. Martin
Professor
Also affiliated: Boston University (2005–2007); University of North Carolina at Chapel Hill (2020); Manitoba Health (2014); Novartis (Switzerland) (2004); Université Libre de Bruxelles (2004–2006); Center for Drug Evaluation and Research (2021); University of Arizona (2021); Georgia College & State University (2003); Johns Hopkins University (2025); University of Namur (2014); University of Georgia (1992–2005); The University of Melbourne (2015); Baldor Electric (United States) (2008); American Association of Colleges of Pharmacy (2002); RTOG Foundation (2001); University of Utah (2013); Augusta University (2002); Avondale University (2016); University Hospitals of Cleveland (2019); Summa Akron City Hospital (1992); University of Arkansas Medical Center (2016–2026); Johns Hopkins Medicine (2025); Institut Jules Bordet (2002–2006); Manchester Royal Infirmary (2001); Jackson Memorial Hospital (2018); University of Mississippi Medical Center (2018); University of Florida (2021); University of Mississippi (2003); Asuragen (United States) (2023); Calgary Laboratory Services (2012); Central Arkansas Veterans Healthcare System (2014–2018); The George Institute for Global Health (2015); Department of Human Services (2017); Michigan Medicine (2021); The Ark (2009); AID Atlanta (2017); 4D (United Kingdom) (2002); G.V. (Sonny) Montgomery VA Medical Center (2018); Medicines Evaluation Unit (2012–2022); Stollery Children's Hospital (2016); Boehringer Ingelheim (United States) (2013); Arkansas Department of Agriculture (2014–2026); Center for Surveillance, Epidemiology, and Laboratory Services (2017); United States Air Force Academy (2022); University of Manitoba (2014); Rockwell Automation (United States) (2006); Florida College (2021); University of Atlanta (1996)
Faculty Researcher
Pharmacy Practice, College of Pharmacy
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Bradley C. Martin's research focuses on investigating health outcomes and treatment patterns, particularly concerning opioid use and cancer therapies. He has studied the associations between chiropractic care and physical therapy with subsequent opioid use in patients experiencing low back pain, as well as trajectories of opioid coverage following long-term opioid therapy initiation among U.S. veterans. His work also includes examining the real-world survival of first-line immune checkpoint inhibitor treatment compared to chemotherapy in older patients with non–small-cell lung cancer and synchronous brain metastases, and adherence to extended venous thromboembolism prophylaxis after complex gastrointestinal oncologic surgery.
Further research by Martin explores the use of data science to improve outcomes for individuals with opioid use disorder and investigates perceptions of HPV vaccination and pharmacist-physician collaboration models to enhance vaccination rates. He has also conducted studies on the association between discontinuing chronic opioid therapy and the onset of substance use disorders, accidents, self-inflicted injuries, and drug overdoses within healthcare systems, as well as a pilot study on opioid overdose counseling and naloxone prescribing in rural community pharmacies.
Martin holds an h-index of 50 with over 11,874 citations and more than 260 publications. He leads a research group and collaborates with several colleagues at the University of Arkansas for Medical Sciences, including Corey J. Hayes, Chenghui Li, Mahip Acharya, and Jacob T. Painter.
Metrics
- h-index: 50
- Publications: 262
- Citations: 11,921
Selected Publications
-
Rural–Urban Differences in Use of Diabetes Self-Management Education and Support in Arkansas, 2015–2019 (2026)
-
Venous thromboembolism following oncologic pancreas and liver surgery (2025)
-
Metformin use is associated with reduced systemic steroid courses among pediatric asthma patients with diabetes or elevated blood glucose levels (2025)
-
Venous thromboembolism diagnosis definition in claims data: implications for research (2025)
-
Disparities in Extended Venous Thromboembolism Prophylaxis After Pancreatic Cancer Surgery (2025)
-
Clinical outcomes of extended venous thromboembolism prophylaxis after oncologic colorectal surgery (2025)
-
An updated view on the influence of initial opioid prescription characteristics on long-term opioid use among opioid naïve patients (2024)
-
The role of prescribed controlled substance acquisition as potential triggers of opioid overdose: A case-crossover study (2024)
-
A Statewide Examination of Medical Cannabis Purchasing Patterns in Arkansas Over the Three Years Immediately Following Legalization (2024)
-
Average Daily Dose Trajectories for Episodes of Buprenorphine Treatment for Opioid Use Disorder. (2024)
-
Are gaps in rates of retention on buprenorphine for treatment of opioid use disorder closing among veterans across different races and ethnicities? A retrospective cohort study (2024)
-
Immune checkpoint inhibitors as subsequent treatment in older adults with non-small cell lung cancer and synchronous brain metastases (2024)
-
Development and validation of machine-learning algorithms predicting retention, overdoses, and all-cause mortality among US military veterans treated with buprenorphine for opioid use disorder (2024)
-
In-Hospital Mortality by Race and Ethnicity Among Hospitalized COVID-19 Patients Using Data From the US National COVID Cohort Collaborative (2024)
-
Opioid therapy trajectories of patients with chronic non-cancer pain over 1 year of follow-up after initiation of short-acting opioid formulations (2024)
Grants & Funding
As listed on this researcher's institutional profile.
- Impact of Opioid Dosing Strategies on Pain Scores and Adverse or Unintended Clinical Outcomes NIH Co-Investigator
- The influence of post-partum coverage extension on maternal depression screening NIH/Nat. Inst. of Child Health & Human Development via Tulane University Principal Investigator
- Arkansas Consortium for Health Services Research NIH Principal Investigator
- Prescribers, Pharmacists, and the Opioid Dilemma NIH/Nat. Inst. on Drug Abuse via RTI, International Co-Investigator
- Use and Abuse of Prescription Opioids Among OEF/OIF Veterans NIH Co-Investigator
- Early Care Decisions and the Risk of Long-Term Opioid Use in Patients with Low Back Pain UAMS Intramural Grant (CTSA) Principal Investigator
- ADVANCING RISK ADJUSTMENT FOR SCHIZOPHRENIA NIH Principal Investigator
- Utilization Patterns and Persistence of Antihormonal Therapies for Breast Cancer NOVARTIS Pharmaceuticals Corporation Principal Investigator
- Development, Validation, and Implementation of an Opioid Risk Prediction Tool UAMS Intramural Grant (CTSA) Principal Investigator
- Duration Limitations and Adherence to Chronic Medication (Incoming Subc from UNC Chapel Hill) Robert Wood Johnson Foundation via University of North Carolina - Chapel Hill Principal Investigator
- Population-Based Analyses of Healthcare Utilization and Outcomes in Users of Medical Marijuana NIH Co-Investigator
- Improving HPV Vaccination using Implementation Strategies in Community Pharmacies NIH Co-Investigator
- UAMS Consortium for Health Service Research Agency for Healthcare Research & Quality Principal Investigator
Collaboration Network
Top Collaborators
- Trajectories of Opioid Coverage After Long-Term Opioid Therapy Initiation Among a National Cohort of US Veterans
- Using Data Science to Improve Outcomes for Persons with Opioid use Disorder
- Association between opioid therapy trajectories and potential opioid‐related adverse health events
- Impact of transitioning from long-term to intermittent opioid therapy on the development of opioid-related adverse outcomes: A retrospective cohort study
- Association Between Pain Intensity and Discontinuing Opioid Therapy or Transitioning to Intermittent Opioid Therapy After Initial Long-Term Opioid Therapy: A Retrospective Cohort Study
Showing 5 of 12 shared publications
- Real-World Survival of First-Line Immune Checkpoint Inhibitor Treatment Versus Chemotherapy in Older Patients With Non–Small-Cell Lung Cancer and Synchronous Brain Metastases
- The use of gabapentinoids and opioids and risk of developing opioid-induced respiratory depression among older breast cancer survivors with neuropathic pain
- Impact of transitioning from long-term to intermittent opioid therapy on the development of opioid-related adverse outcomes: A retrospective cohort study
- Association Between Pain Intensity and Discontinuing Opioid Therapy or Transitioning to Intermittent Opioid Therapy After Initial Long-Term Opioid Therapy: A Retrospective Cohort Study
- Healthcare costs and utilization associated with pain among breast cancer survivors: a propensity score matched cohort study using SEER-Medicare data
Showing 5 of 10 shared publications
- Real-World Survival of First-Line Immune Checkpoint Inhibitor Treatment Versus Chemotherapy in Older Patients With Non–Small-Cell Lung Cancer and Synchronous Brain Metastases
- The use of gabapentinoids and opioids and risk of developing opioid-induced respiratory depression among older breast cancer survivors with neuropathic pain
- Factors Associated With Guideline-Concordant Pharmacological Treatment for Neuropathic Pain Among Breast Cancer Survivors
- Healthcare costs and utilization associated with pain among breast cancer survivors: a propensity score matched cohort study using SEER-Medicare data
- Opioid therapy trajectories of patients with chronic non-cancer pain over 1 year of follow-up after initiation of short-acting opioid formulations
Showing 5 of 8 shared publications
- Associations Between Early Chiropractic Care and Physical Therapy on Subsequent Opioid Use Among Persons With Low Back Pain in Arkansas
- Opioid therapy trajectories of patients with chronic non-cancer pain over 1 year of follow-up after initiation of short-acting opioid formulations
- Development of a potential opioid misuse measure from administrative dispensing data and contrasting opioid misuse among individuals on long-term tramadol, long-term short-acting hydrocodone or long-term short-acting oxycodone therapy in Arkansas
- Statewide trends and factors associated with genetic testing for hereditary cancer risk in Arkansas 2013–2018
- PDG39 Evaluating the Temporal Association between the Recency of Prescribed Controlled Substance Acquisition and Fatal and Non-Fatal Opioid Overdose
Showing 5 of 7 shared publications
- Impact of transitioning from long-term to intermittent opioid therapy on the development of opioid-related adverse outcomes: A retrospective cohort study
- Association Between Pain Intensity and Discontinuing Opioid Therapy or Transitioning to Intermittent Opioid Therapy After Initial Long-Term Opioid Therapy: A Retrospective Cohort Study
- Average Daily Dose Trajectories for Episodes of Buprenorphine Treatment for Opioid Use Disorder.
- Development and validation of machine-learning algorithms predicting retention, overdoses, and all-cause mortality among US military veterans treated with buprenorphine for opioid use disorder
- Are gaps in rates of retention on buprenorphine for treatment of opioid use disorder closing among veterans across different races and ethnicities? A retrospective cohort study
Showing 5 of 6 shared publications
- The use of gabapentinoids and opioids and risk of developing opioid-induced respiratory depression among older breast cancer survivors with neuropathic pain
- Factors Associated With Guideline-Concordant Pharmacological Treatment for Neuropathic Pain Among Breast Cancer Survivors
- Healthcare costs and utilization associated with pain among breast cancer survivors: a propensity score matched cohort study using SEER-Medicare data
- Opioid therapy trajectories of patients with chronic non-cancer pain over 1 year of follow-up after initiation of short-acting opioid formulations
- Development of a potential opioid misuse measure from administrative dispensing data and contrasting opioid misuse among individuals on long-term tramadol, long-term short-acting hydrocodone or long-term short-acting oxycodone therapy in Arkansas
Showing 5 of 6 shared publications
- Adherence to Extended Venous Thromboembolism Prophylaxis and Outcomes After Complex Gastrointestinal Oncologic Surgery
- Clinical outcomes of extended venous thromboembolism prophylaxis after oncologic colorectal surgery
- Disparities in Extended Venous Thromboembolism Prophylaxis After Pancreatic Cancer Surgery
- Venous thromboembolism diagnosis definition in claims data: implications for research
- ASO Visual Abstract: Adherence to and Outcomes of Extended Venous Thromboembolism Prophylaxis After Complex Gastrointestinal Oncologic Surgery
- Adherence to Extended Venous Thromboembolism Prophylaxis and Outcomes After Complex Gastrointestinal Oncologic Surgery
- Clinical outcomes of extended venous thromboembolism prophylaxis after oncologic colorectal surgery
- Disparities in Extended Venous Thromboembolism Prophylaxis After Pancreatic Cancer Surgery
- Venous thromboembolism diagnosis definition in claims data: implications for research
- ASO Visual Abstract: Adherence to and Outcomes of Extended Venous Thromboembolism Prophylaxis After Complex Gastrointestinal Oncologic Surgery
- Using Data Science to Improve Outcomes for Persons with Opioid use Disorder
- Average Daily Dose Trajectories for Episodes of Buprenorphine Treatment for Opioid Use Disorder.
- Development and validation of machine-learning algorithms predicting retention, overdoses, and all-cause mortality among US military veterans treated with buprenorphine for opioid use disorder
- Are gaps in rates of retention on buprenorphine for treatment of opioid use disorder closing among veterans across different races and ethnicities? A retrospective cohort study
- Using Data Science to Improve Outcomes for Persons with Opioid use Disorder
- Average Daily Dose Trajectories for Episodes of Buprenorphine Treatment for Opioid Use Disorder.
- Development and validation of machine-learning algorithms predicting retention, overdoses, and all-cause mortality among US military veterans treated with buprenorphine for opioid use disorder
- Are gaps in rates of retention on buprenorphine for treatment of opioid use disorder closing among veterans across different races and ethnicities? A retrospective cohort study
- The use of gabapentinoids and opioids and risk of developing opioid-induced respiratory depression among older breast cancer survivors with neuropathic pain
- Factors Associated With Guideline-Concordant Pharmacological Treatment for Neuropathic Pain Among Breast Cancer Survivors
- Healthcare costs and utilization associated with pain among breast cancer survivors: a propensity score matched cohort study using SEER-Medicare data
- Breast Cancer Survivor Risk of Respiratory Depression Associated with Gabapentin and Opioids
- The use of gabapentinoids and opioids and risk of developing opioid-induced respiratory depression among older breast cancer survivors with neuropathic pain
- Factors Associated With Guideline-Concordant Pharmacological Treatment for Neuropathic Pain Among Breast Cancer Survivors
- Healthcare costs and utilization associated with pain among breast cancer survivors: a propensity score matched cohort study using SEER-Medicare data
- Breast Cancer Survivor Risk of Respiratory Depression Associated with Gabapentin and Opioids
- Perceptions of HPV vaccination and pharmacist-physician collaboration models to improve HPV vaccination rates
- Opioid overdose counseling and prescribing of naloxone in rural community pharmacies: A pilot study
- Rural–Urban Differences in Use of Diabetes Self-Management Education and Support in Arkansas, 2015–2019
- The role of prescribed controlled substance acquisition as potential triggers of opioid overdose: A case-crossover study
- PDG39 Evaluating the Temporal Association between the Recency of Prescribed Controlled Substance Acquisition and Fatal and Non-Fatal Opioid Overdose
- EPH37 The Role of Prescribed Controlled Substance Acquisition As Potential Triggers of Opioid Overdose: A Case-Crossover Study
- Statewide trends and factors associated with genetic testing for hereditary cancer risk in Arkansas 2013–2018
- PIH14 Statewide Trends in Genetic Testing for Hereditary Cancers in Arkansas 2013-2018
- EPH111 Factors Associated with Cancer Prevention Surgeries for Hereditary Cancer Risk in Arkansas 2013-2018
Similar Researchers
Based on overlapping research topics